Despite the fact that mutation/inactivation of p53 and Pten has been extensively studied and is implicated in HCC development, there is a lack of direct evidence supporting the role of p53 and Pten loss in initiating tumor formation in the liver during HBV infection. The gene discussed is PTEN; the disease is hepatocellular carcinoma.